 Navin Fluorine International Ltd approves capex
Navin Fluorine International Ltd approves capex Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart
Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets
Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets IPO Note - Lenskart Solutions Ltd - Reliance Securities
IPO Note - Lenskart Solutions Ltd - Reliance Securities IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025
IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025 
              The Compensation Committee of the Board of Ajanta Pharma Ltd has at its meeting held today has allotted 1,000 fully paid up equity shares of Rs. 2/- each, upon exercise of options. In view of the above, the paid up capital of the Company stands increased to Rs. 17,60,12,000 consisting 8,80,06,0000 equity shares of Rs. 2/- each.
The committee has granted further options under Employees Stock Option Scheme - 2011 (ESOS SCHEME 2011). Total number of options granted was 2,000 and the number of shares covered under options - 1 share per option. The Exercise Period is one month from vesting date Company will be making application for listing of these shares in due course.
Shares of AJANTA PHARMA LTD. was last trading in BSE at Rs.1603 as compared to the previous close of Rs. 1580.15. The total number of shares traded during the day was 14746 in over 918 trades.
The stock hit an intraday high of Rs. 1612.95 and intraday low of 1555. The net turnover during the day was Rs. 23224872.